Health Care & Life Sciences » Pharmaceuticals | Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
147,285.00
214,161.00
283,703.00
346,620.00
507,666.00
599,674
SG&A Expense
189,169.00
252,487.00
347,346.00
381,606.00
474,383.00
645,898
EBIT
51,666.00
47,730.00
-
44,019.00
24,934.00
60,572
Unusual Expense
-
8,292.00
1,881.00
6,280.00
8,089.00
800
Non Operating Income/Expense
2,378.00
21,158.00
20,286.00
56.00
3,174.00
182
Interest Expense
19,355.00
22,209.00
36,732.00
38,795.00
44,752.00
44,789
Pretax Income
66,558.00
54,391.00
87,906.00
83,622.00
23,276.00
76,156
Income Tax
5,914.00
15,407.00
372.00
2,934.00
5,980.00
291,141
Consolidated Net Income
60,644.00
38,984.00
88,278.00
86,556.00
1,665.00
218,112
Net Income
60,644.00
38,984.00
88,278.00
86,556.00
9,661.00
276,868
Net Income After Extraordinaries
60,644.00
38,984.00
88,278.00
86,556.00
9,661.00
276,868
Net Income Available to Common
60,644.00
38,984.00
88,278.00
86,556.00
9,661.00
276,868
EPS (Basic)
0.55
0.33
0.74
0.72
0.08
2.07
Basic Shares Outstanding
110,502.00
117,691.00
119,719.00
120,933.00
124,016.00
132,320
EPS (Diluted)
0.55
0.33
0.74
0.72
0.08
2.07
Diluted Shares Outstanding
110,502.00
117,691.00
119,719.00
120,933.00
126,098.00
134,056
EBITDA
41,884.00
38,326.00
63,643.00
34,986.00
33,283.00
48,044
Non-Operating Interest Income
2,085.00
2,682.00
4,302.00
5,416.00
7,805.00
30,187
Minority Interest Expense
-
-
-
-
11,326.00
58,756
Other After Tax Income (Expense)
-
-
-
-
15,631.00
3,127

About Ionis Pharmaceuticals

View Profile
Address
2855 Gazelle Court
Carlsbad California 92010
United States
Employees -
Website http://www.ionispharm.com
Updated 07/08/2019
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.